THE CONCEPT OF SELECTIVITY IN 5-HT RECEPTOR RESEARCH

被引:408
作者
VANWIJNGAARDEN, I
TULP, MTM
SOUDIJN, W
机构
[1] DUPHAR BV, DEPT MED CHEM, 1380 DA WEESP, NETHERLANDS
[2] DUPHAR BV, DEPT PHARMACOL, 1380 DA WEESP, NETHERLANDS
[3] CTR BIOPHARMACEUT SCI, DIV MED CHEM, 2300 RA LEIDEN, NETHERLANDS
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1990年 / 188卷 / 06期
关键词
5-HT RECEPTOR SUBTYPES; 5-HT RECEPTOR AGONISTS; 5-HT RECEPTOR ANTAGONISTS; (RECEPTOR BINDING PROFILES); (SELECTIVITY);
D O I
10.1016/0922-4106(90)90190-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since the demonstration that serotonin (5-hydroxytryptamine, 5-HT) interacts with different (sub)types of membrane receptors, several compounds have been proposed as potent and selective ligands for one of these 5-HT subtypes. Unfortunately, specific and highly selective ligands (selectivity ratios greater-than-or-equal-to 1000) for the majority of 5-HT subtypes are still lacking. A few compounds are selective (ratios greater-than-or-equal-to 100), but most of the reputed 'selective' tools display affinities for other 5-HT subtypes and/or other (neuro-) transmitter receptors. Mainly due to different interpretations of the concept of selectivity, many of these nonselective compounds are still used to characterize 5-HT receptors. In this paper, we present the affinities (obtained by radioligand binding studies) of the most selective tools known today for each of the 5-HT subtypes and discuss the structure-activity relationships of some interesting series. The potential use of several of these selective ligands as pharmacological tools and therapeutics will be briefly reviewed.
引用
收藏
页码:301 / 312
页数:12
相关论文
共 47 条
[1]  
BJORK L, 1989, J MED CHEM, V32, P779
[2]  
CARR AA, 1989, INT S SEROTONIN FLOR, P10
[3]  
COHEN ML, 1989, J PHARMACOL EXP THER, V248, P197
[4]  
COHEN ML, 1983, J PHARMACOL EXP THER, V227, P327
[5]   CENTRAL SEROTONIN RECEPTORS - EFFECTOR SYSTEMS, PHYSIOLOGICAL ROLES AND REGULATION [J].
CONN, PJ ;
SANDERSBUSH, E .
PSYCHOPHARMACOLOGY, 1987, 92 (03) :267-277
[6]   NEUROANATOMICAL SITES OF ACTION OF 5-HT3 RECEPTOR AGONIST AND ANTAGONISTS FOR ALTERATION OF AVERSIVE BEHAVIOR IN THE MOUSE [J].
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :325-332
[7]  
DARCHEN F, 1988, MOL PHARMACOL, V33, P672
[8]   PHARMACOLOGICAL EFFECTS OF MDL-11,939 - A SELECTIVE, CENTRALLY ACTING ANTAGONIST OF 5-HT2 RECEPTORS [J].
DUDLEY, MW ;
WIECH, NL ;
MILLER, FP ;
CARR, AA ;
CHENG, HC ;
ROEBEL, LE ;
DOHERTY, NS ;
YAMAMURA, HI ;
URSILLO, RC ;
PALFREYMAN, MG .
DRUG DEVELOPMENT RESEARCH, 1988, 13 (01) :29-43
[9]   THE GASTROINTESTINAL PROKINETIC BENZAMIDE DERIVATIVES ARE AGONISTS AT THE NON-CLASSICAL 5-HT RECEPTOR (5-HT4) POSITIVELY COUPLED TO ADENYLATE-CYCLASE IN NEURONS [J].
DUMUIS, A ;
SEBBEN, M ;
BOCKAERT, J .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1989, 340 (04) :403-410
[10]   INDAZOLES AS INDOLE BIOISOSTERES - SYNTHESIS AND EVALUATION OF THE TROPANYL ESTER AND AMIDE OF INDAZOLE-3-CARBOXYLATE AS ANTAGONISTS AT THE SEROTONIN 5HT3 RECEPTOR [J].
FLUDZINSKI, P ;
EVRARD, DA ;
BLOOMQUIST, WE ;
LACEFIELD, WB ;
PFEIFER, W ;
JONES, ND ;
DEETER, JB ;
COHEN, ML .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (09) :1535-1537